<i>Experimental immunology</i><br>Anti-Toll-like receptor 2 antibody, T2.1,
reduces tumor necrosis factor α and
interleukin-6 release and inhibits nuclear
factor κB expression in bacterial lipoprotein
stimulated THP-1 cells

Min Huang; Jing Zhou; Liqing Bi; Qian Zhang; Suming Zhou

eISSN: 1644-4124
ISSN: 1426-3912

Central European Journal of Immunology

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

1/2012
vol. 37

Send email

Copy url:

abstract:

Experimental immunology
Anti-Toll-like receptor 2 antibody, T2.1, reduces tumor necrosis factor α and interleukin-6 release and inhibits nuclear factor κB expression in bacterial lipoprotein stimulated THP-1 cells

Min Huang

,

Jing Zhou

,

Liqing Bi

,

Qian Zhang

,

Suming Zhou

(Centr Eur J Immunol 2012; 37 (1): 6-10)

Online publish date: 2012/03/29

View full text Get citation

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Huang M, Zhou J, Bi L, Zhang Q, Zhou S. Experimental immunologyAnti-Toll-like receptor 2 antibody, T2.1,
reduces tumor necrosis factor α and
interleukin-6 release and inhibits nuclear
factor κB expression in bacterial lipoprotein
stimulated THP-1 cells. Central European Journal of Immunology. 2012;37(1):6-10.

APA

Huang, M., Zhou, J., Bi, L., Zhang, Q.,  & Zhou, S. (2012). Experimental immunologyAnti-Toll-like receptor 2 antibody, T2.1,
reduces tumor necrosis factor α and
interleukin-6 release and inhibits nuclear
factor κB expression in bacterial lipoprotein
stimulated THP-1 cells. Central European Journal of Immunology, 37(1), 6-10.

Chicago

Huang, Min, Jing Zhou, Liqing Bi, Qian Zhang,  and Suming Zhou. 2012. "Experimental immunologyAnti-Toll-like receptor 2 antibody, T2.1,
reduces tumor necrosis factor α and
interleukin-6 release and inhibits nuclear
factor κB expression in bacterial lipoprotein
stimulated THP-1 cells". Central European Journal of Immunology 37 (1): 6-10.

Harvard

Huang, M., Zhou, J., Bi, L., Zhang, Q.,  and Zhou, S. (2012). Experimental immunologyAnti-Toll-like receptor 2 antibody, T2.1,
reduces tumor necrosis factor α and
interleukin-6 release and inhibits nuclear
factor κB expression in bacterial lipoprotein
stimulated THP-1 cells. Central European Journal of Immunology, 37(1), pp.6-10.

MLA

Huang, Min et al. "Experimental immunologyAnti-Toll-like receptor 2 antibody, T2.1,
reduces tumor necrosis factor α and
interleukin-6 release and inhibits nuclear
factor κB expression in bacterial lipoprotein
stimulated THP-1 cells." Central European Journal of Immunology, vol. 37, no. 1, 2012, pp. 6-10.

Vancouver

Huang M, Zhou J, Bi L, Zhang Q, Zhou S. Experimental immunologyAnti-Toll-like receptor 2 antibody, T2.1,
reduces tumor necrosis factor α and
interleukin-6 release and inhibits nuclear
factor κB expression in bacterial lipoprotein
stimulated THP-1 cells. Central European Journal of Immunology. 2012;37(1):6-10.

This study analyzed the effects of a blocking anti-Toll-like receptor 2 (TLR2) antibody (T2.1) on TLR2 signaling and inflammatory cytokine production by bacterial lipoprotein (BLP) stimulated THP-1 cells. Cells were treated sequentially with anti-TLR2 antibody and BLP (A + B) or in the reverse order (B + A), or directly stimulated with BLP (B). Blank and isotype control groups were included. Tumor necrosis factor α (TNF-α) and interleukin-6 (IL-6) concentrations were measured by ELISA. Expression of nuclear factor κB (NF-κB), TLR2 and myeloid differentiation factor 88 (MyD88) was analyzed by Western Blot. Significantly higher expression of TNF-α, IL-6 and NF-κB was detected in all groups compared with the blank control (P < 0.05), although expression was significantly lower in A + B and B + A compared with the isotype control and B (P > 0.05). However, no significant differences were detected in TLR2 and MyD88 expression among these groups (P > 0.05). These data demonstrated that anti-TLR2 antibody significantly reduced TNF-α, IL-6 and NF-κB expression by BLP-stimulated THP-1 cells, thus indicating the protective value of this antibody in vivo.

keywords:

Experimental immunologyAnti-Toll-like receptor 2 antibody, T2.1, reduces tumor necrosis factor α and interleukin-6 release and inhibits nuclear factor κB expression in bacterial lipoprotein stimulated THP-1 cells

Min Huang , Jing Zhou , Liqing Bi , Qian Zhang , Suming Zhou

anti-TLR2 antibody, BLP, NF-κB, TNF-α, IL-6

Experimental immunology
Anti-Toll-like receptor 2 antibody, T2.1, reduces tumor necrosis factor α and interleukin-6 release and inhibits nuclear factor κB expression in bacterial lipoprotein stimulated THP-1 cells

Min Huang

,

Jing Zhou

,

Liqing Bi

,

Qian Zhang

,

Suming Zhou